Procurement Summary
Country: Slovakia
Summary: Laronidase, 100 U/ml Infusion Concentrate
Deadline: 10 Aug 2022
Posting Date: 11 Jul 2022
Other Information
Notice Type: Tender
TOT Ref.No.: 68821145
Document Ref. No.: 372754-2022
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: EUR 122212.50
CPV Classification
33698300 - Peptic substances
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Document Type: Contract Notice
Title: Laronidase, 100 U/ml infusion concentrate
Reference Number: 84-2022
Contract Type: Supplies
Estimated Value: 122212.50 - EUR
Description: The medicine is used to treat patients with MPS I disease (mucopolysaccharidosis I). It is administered for the treatment of non -urological manifestations of this disease.
The medicine is a synthetic enzyme called laponidase. It can replace the natural enzyme, which is also lack of MPS
33698300 - Peptic substances
Authority Type: Body Governed by Public Law
Type of Procedure: Open procedure
Regulation: European Union, with Participation by GPA Countries
BID TYPE: Submission for All Lots
DOC TITLE: Peptic Substance
Dispatch Date: 2022-07-06
Publish Date: 2022-07-11
Submission Date: 2022-08-10
Documents
Tender Notice